Cited In for PMID: 30337455

Year	Number of Results
2018	1
2019	27
2020	52
2021	85
2022	101
2023	86
2024	17

1

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.

Harrington LB, Burstein D, Chen JS, Paez-Espino D, Ma E, Witte IP, Cofsky JC, Kyrpides NC, Banfield JF, Doudna JA. Harrington LB, et al. Science. 2018 Nov 16;362(6416):839-842. doi: 10.1126/science.aav4294. Epub 2018 Oct 18. Science. 2018. PMID: 30337455 Free PMC article.

2

Advances in miniature CRISPR-Cas proteins and their applications in gene editing.

Wu H, Sun Y, Wang Y, Luo L, Song Y. Wu H, et al. Arch Microbiol. 2024 Apr 23;206(5):231. doi: 10.1007/s00203-024-03962-0. Arch Microbiol. 2024. PMID: 38652321 Review.

3

Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases.

Lei Y, Xu D. Lei Y, et al. Molecules. 2024 Mar 29;29(7):1527. doi: 10.3390/molecules29071527. Molecules. 2024. PMID: 38611806 Free PMC article. Review.

4

Utilization of CRISPR-Cas genome editing technology in filamentous fungi: function and advancement potentiality.

Shen Q, Ruan H, Zhang H, Wu T, Zhu K, Han W, Dong R, Ming T, Qi H, Zhang Y. Shen Q, et al. Front Microbiol. 2024 Mar 28;15:1375120. doi: 10.3389/fmicb.2024.1375120. eCollection 2024. Front Microbiol. 2024. PMID: 38605715 Free PMC article. Review.

5

Identification of Viruses Infecting Phalaenopsis Orchids Using Nanopore Sequencing and Development of an RT-RPA-CRISPR/Cas12a for Rapid Visual Detection of Nerine Latent Virus.

Lee HJ, Kim HJ, Cho IS, Jeong RD. Lee HJ, et al. Int J Mol Sci. 2024 Feb 25;25(5):2666. doi: 10.3390/ijms25052666. Int J Mol Sci. 2024. PMID: 38473916 Free PMC article.

6

Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology.

Tao R, Han X, Bai X, Yu J, Ma Y, Chen W, Zhang D, Li Z. Tao R, et al. Front Immunol. 2024 Feb 21;15:1354825. doi: 10.3389/fimmu.2024.1354825. eCollection 2024. Front Immunol. 2024. PMID: 38449862 Free PMC article. Review.

7

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges.

Zhou J, Li Z, Seun Olajide J, Wang G. Zhou J, et al. Heliyon. 2024 Feb 14;10(4):e26179. doi: 10.1016/j.heliyon.2024.e26179. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38390187 Free PMC article. Review.

8

Metabolic reprogramming in the tumor microenvironment of liver cancer.

Lin J, Rao D, Zhang M, Gao Q. Lin J, et al. J Hematol Oncol. 2024 Jan 31;17(1):6. doi: 10.1186/s13045-024-01527-8. J Hematol Oncol. 2024. PMID: 38297372 Free PMC article. Review.

9

Targeted mutagenesis in mice via an engineered AsCas12f1 system.

Fan P, Wang H, Zhao F, Zhang T, Li J, Sun X, Yu Y, Xiong H, Lai L, Sui T. Fan P, et al. Cell Mol Life Sci. 2024 Jan 28;81(1):63. doi: 10.1007/s00018-023-05100-3. Cell Mol Life Sci. 2024. PMID: 38280977 Free PMC article.

10

Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model.

Li Z, Guo R, Sun X, Li G, Shao Z, Huo X, Yang R, Liu X, Cao X, Zhang H, Zhang W, Zhang X, Ma S, Zhang M, Liu Y, Yao Y, Shi J, Yang H, Hu C, Zhou Y, Xu C. Li Z, et al. Nat Commun. 2024 Jan 27;15(1):831. doi: 10.1038/s41467-024-45197-z. Nat Commun. 2024. PMID: 38280857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year